C Pradier to HIV Infections
This is a "connection" page, showing publications C Pradier has written about HIV Infections.
Connection Strength
0.345
-
Evolution of HIV-1 transmitted drug resistance in Italy in the 2007-2014 period: A weighted analysis. J Clin Virol. 2018 09; 106:49-52.
Score: 0.060
-
Correlates of frailty phenotype and frailty index and their associations with clinical outcomes. HIV Med. 2017 11; 18(10):764-771.
Score: 0.056
-
Age of HIV Acquisition Affects the Risk of Multi-Morbidity after 25 Years of Infection Exposure. J Frailty Aging. 2019; 8(2):88-92.
Score: 0.031
-
Is active hepatitis C associated with the size of HIV reservoir in successfully treated patients? J Clin Virol. 2018 11; 108:103-104.
Score: 0.030
-
Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens. HIV Med. 2018 02; 19(2):102-117.
Score: 0.028
-
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14. J Antimicrob Chemother. 2017 10 01; 72(10):2837-2845.
Score: 0.028
-
The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people. HIV Med. 2018 02; 19(2):90-101.
Score: 0.028
-
Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations. HIV Med. 2014 Nov; 15(10):595-603.
Score: 0.022
-
Immunological and virological effects of long term IL-2 therapy in HIV-1-infected patients. AIDS. 2001 Sep 07; 15(13):1729-31.
Score: 0.018
-
Timing of human immunodeficiency virus type 1 (HIV-1) transmission from mother to child: bayesian estimation using a mixture. Stat Med. 1999 Apr 15; 18(7):815-33.
Score: 0.016
-
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles? J Infect Dis. 2004 Mar 15; 189(6):1056-74.
Score: 0.011
-
Mandatory prenatal screening for the human immunodeficiency virus: the experience in south-eastern France of a national policy, 1992-1994. Br J Obstet Gynaecol. 1998 Mar; 105(3):269-74.
Score: 0.007
-
What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM. EBioMedicine. 2018 Jan; 27:51-60.
Score: 0.007
-
Reduced incidence of Kaposi's sarcoma and of systemic non-hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy. Int J Cancer. 2003 Jan 01; 103(1):142-4.
Score: 0.003